Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
INSM News
Cantor Fitzgerald assumed coverage of Insmed (INSM) with an Overweight rating and $192 price target Following a strong re-rating, Insmed has become a popular lo...
On October 17, 2025, Insmed Incorporated announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive...
Insmed ((INSM)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
Analyst ratings
95%
of 20 ratingsMore INSM News
Analyst Ashwani Verma from UBS maintained a Buy rating on Insmed and keeping the price target at $194.00. Elevate Your Investing Strategy: Take advantage of Tip...
If you have been watching Insmed stock lately, you are not alone. With the shares coming off a remarkable year-to-date gain of 129.3% and a three-year return th...